MariMed Q2 revenue $33.0M (+1% YoY); GAAP net income falls 75% to $1.9M

MARIMED INC.

2022-Q2 EPS reported $0.02 revenue$64,268,000

Revenue $33.0M vs $32.6M year ago; gross margin dropped to 45% from 60%.
GAAP net income $1.9M vs $7.6M; Non-GAAP Adjusted EBITDA $8.9M vs $13.9M.
Working capital declined to $8.9M from $13.9M; no guidance provided.
CEO cited increased dispensary traffic despite industry headwinds and 40-year high inflation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.